VPS35 regulates parkin substrate AIMP2 toxicity by facilitating lysosomal clearance of AIMP2open access
- Authors
- Yun, Seung Pil; Kim, Hyojung; Ham, Sangwoo; Kwon, Seung-Hwan; Lee, Gum Hwa; Shin, Joo-Ho; Lee, Sang Hun; Ko, Han Seok; Lee, Yunjong
- Issue Date
- Apr-2017
- Publisher
- Nature Publishing Group
- Keywords
- VPS35; AIMP2; Parkinson’s disease
- Citation
- Cell Death and Disease, v.8
- Journal Title
- Cell Death and Disease
- Volume
- 8
- URI
- https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/7667
- DOI
- 10.1038/cddis.2017.157
- ISSN
- 2041-4889
- Abstract
- Vacuolar protein sorting-associated protein 35 (VPS35) is involved in retrograde transport of proteins from endosomes to trans-Golgi network. Gene mutations in VPS35 are linked to autosomal dominant late-onset Parkinson's disease (PD). Although the identification of VPS35 mutations has provided novel insight about its interactions with several PD-associated genes including leucine-rich repeat kinase 2 (LRRK2) and a-synuclein, little information is available about the molecular mechanisms of cell death downstream of VPS35 dysfunction. In this study, we showed that VPS35 has a role in the lysosomal degradation of parkin substrate aminoacyl tRNA synthetase complex-interacting multifunctional protein 2 (AIMP2), of which accumulation leads to poly (ADP-ribose) polymerase-1 (PARP1)-dependent cell death. VPS35 was co-immunoprecipitated with AIMP2, as well as lysosome-associated membrane protein-2a (Lamp2a). Interestingly, this association was disrupted by PD-associated VPS35 mutant D620N. VPS35 overexpression prevented AIMP2-potentiated cell death and PARP1 activation in SH-SY5Y cells. More importantly, knockdown of VPS35 led to PARP1 activation and cell death, which was AIMP2 dependent. These findings provide new mechanistic insights into the role of VPS35 in the regulation of AIMP2 levels and cell death. As AIMP2 accumulation was reported in PD patient's brains and involved in dopaminergic cell death, identification of VPS35 as a novel regulator of AIMP2 clearance via lysosomal pathway provides alternative venue to control dopaminergic cell death in PD.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Medicine > Department of Biochemistry > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/7667)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.